Universal Ibogaine owns the global licensing rights to the life saving protocol and is working on a clinical trial in Canada to medicalize the ibogaine molecule. It is a plant medicine that can cure someone of opioid addiction in one dose. This company is developing a worldwide treatment center network.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.